Mutation analysis in liver tumor organoids revealed mutations in key cancer-associated genes, such as TP53 and KRAS, supporting their relevance for studying key molecular drivers of biliary tract cancers and drug response modeling. The gene discussed is KRAS; the disease is biliary tract neoplasm.